Jorge Cortes, M.D.
Jane and John Justin Distinguished Chair in Leukemia Research Section Chief of AML & CML Deputy Chairman, Department of Leukemia The University of Texas MD Anderson Cancer Center Houston, Texas Jorge Cortes, MD, is deputy chair and professor of medicine in the Department of Leukemia at MD Anderson Cancer Center, Houston Texas where he directs the CML and AML Programs. Dr. Cortes received his medical degree in 1986 from the Universidad Nacional Autonoma de Mexico, Mexico City, and has been at MD Anderson Cancer Center since 1991. Dr. Cortes, whose clinical interest focus on new drug development and the management of patients with myelodysplastic syndromes, acute and chronic leukemias, and myeloproliferative disorders has authored over 700 peer-reviewed medical publications in top-tier journals including New England Journal of Medicine, Lancet Oncology, Lancet Hematology, Journal of Clinical Oncology, Leukemia, Blood and many others. He has authored several books and book chapters in prestigious publications such as Cancer Medicine and Harrison’s Principles of Internal Medicine.
He has received numerous awards including the Faculty Scholar Award from MD Anderson Cancer Center in 2003, the Annual Celgene Young Investigator Achievement Award for Clinical Research in Hematology in 2005, The Dr. John J. Kenny Award from The Leukemia & Lymphoma Society in 2006, the Service to Mankind Award from The Leukemia & Lymphoma Society in 2007, the Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research from MD Anderson Cancer Center in 2007, The Professor David Galton Lecture from the Imperial College of London Hammersmith Hospital in London, UK in 2011, the William Randolph Hearst Foundations Faculty Achievement Award in Education in 2013, and The Gerald P. Bodey Award for Excellence in Education in 2014. He was listed in Listed in “A list of highly influential biomedical researchers, 1996-2011,” Boyack et al. Eur. J. Clin Invest, 2013, and named among the Highly Cited Researchers in 2014 by Thomson Reuters in 2014.
Dr. Cortes is an Associate Editor for Blood and serves in the Editorial Board of the Journal of Clinical Oncology, Clinical Cancer Research, Leukemia and Lymphoma and the American Journal of Hematology. Dr. Cortes is a member of the Board of Directors of the International CML Foundation and President of the Latin American LeukemiaNet. He led the development of three drugs that were eventually FDA approved for the treatment of CML in 2012. Dr. Cortes is Chair of the Executive Institutional Review Board (IRB) and Chair of the Executive Committee of the Medical Staff at MD Anderson Cancer Center, and program director of the Leukemia Fellowship Program.